The Cyp27b1 enzyme (25-hydroxyvitamin D-1␣-hydroxylase) that converts 25-hydroxyvitamin D into the active metabolite, 1,25-dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ], is expressed in kidney but also in other cell types such as chondrocytes. This suggests that local production of 1,25(OH) 2 D 3 could play an important role in the differentiation of these cells. To test this hypothesis, we engineered mutant mice that do not express the Cyp27b1 gene in chondrocytes. Inactivation of both alleles of the Cyp27b1 gene led to decreased RANKL expression and reduced osteoclastogenesis, increased width of the hypertrophic zone of the growth plate at embryonic d 15.5, increased bone volume in neonatal long bones, and increased expression of the chondrocytic differentiation markers Indian Hedgehog and PTH/PTHrP receptor. The expression of the angiogenic marker VEGF was decreased, accompanied by decreased platelet/endothelial cell adhesion molecule-1 staining in the neonatal growth plate, suggesting a delay in vascularization. In parallel, we engineered strains of mice overexpressing a Cyp27b1 transgene in chondrocytes by coupling the Cyp27b1 cDNA to the collagen ␣ 1 (II) promoter. The transgenic mice showed a mirror image phenotype when compared with the tissue-specific inactivation, i.e. a reduction in the width of the hypertrophic zone of the embryonic growth plate, decreased bone volume in neonatal long bones, and inverse expression patterns of chondrocytic differentiation markers. These results support an intracrine role of 1,25(OH) 2 2), is responsible for intestinal calcium and phosphorus absorption, mobilization of calcium from bone, and renal reabsorption of calcium and phosphorus (1). Expression of Cyp27b1 has long been thought to be confined to the proximal convoluted tubules of the kidney, and circulating concentrations of 1,25(OH) 2 D 3 primarily reflect its renal synthesis (1). However, Cyp27b1 expression was detected throughout the nephron (3) as well as in keratinocytes, macrophages, chondrocytes and osteoblasts (4). The identification of these extrarenal sites of expression of Cyp27b1 has led investigators to hypothesize that local production of 1,25(OH) 2 D 3 could play an important autocrine or paracrine role in the differentiation and function of these cells. Strong support for this model has been obtained for Toll-like receptor-mediated innate immunity in macrophages (5, 6). In bone, the classical view is that vitamin D exerts its effects indirectly via control of calcium and phosphate homeostasis, despite
T
he mitochondrial cytochrome P450 enzyme, 25-hydroxyvitamin D-1␣-hydroxylase (Cyp27b1), catalyzes the conversion of 25-hydroxyvitamin D 3 (25OHD 3 ) to 1,25-dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ], the hormonal form of the vitamin (1) . This active metabolite, acting through its well-characterized vitamin D receptor (VDR) (2) , is responsible for intestinal calcium and phosphorus absorption, mobilization of calcium from bone, and renal reabsorption of calcium and phosphorus (1) . Expression of Cyp27b1 has long been thought to be confined to the proximal convoluted tubules of the kidney, and circulating concentrations of 1,25(OH) 2 D 3 primarily reflect its renal synthesis (1) . However, Cyp27b1 expression was detected throughout the nephron (3) as well as in keratinocytes, macrophages, chondrocytes and osteoblasts (4) . The identification of these extrarenal sites of expression of Cyp27b1 has led investigators to hypothesize that local production of 1,25(OH) 2 D 3 could play an important autocrine or paracrine role in the differentiation and function of these cells. Strong support for this model has been obtained for Toll-like receptor-mediated innate immunity in macrophages (5, 6) . In bone, the classical view is that vitamin D exerts its effects indirectly via control of calcium and phosphate homeostasis, despite expression of Cyp27b1 and the VDR in osteoblasts and chondrocytes (7) (8) (9) . However, recent molecular genetic studies have revealed direct but nonessential roles for 1,25(OH) 2 D 3 -mediated signaling in growth plate chondrocytes. Specific inactivation of the VDR in collagen type II-expressing chondrocytes leads to delayed osteoclastogenesis, which causes a transient increase in bone volume at the primary spongiosa (10) .
We generated both chondrocyte-specific Cyp27b1 lossof-function and overexpression mice models to further substantiate the physiological role of the 25-hydroxyvitamin D-1␣-hydroxylase in growth plate chondrocytes. Our results agree with the phenotype observed in chondrocyte-specific VDR-ablated mice (10) and support a role for locally synthesized 1,25(OH) 2 D 3 in the neovascularization of the growth plate.
Materials and Methods

Animals
Animal care and use followed the ethical guidelines of the Canadian Council on Animal Care and were reviewed and approved by the Institutional Animal Care and Use Committee. Mice heterozygous for the Cyp27b1 null allele (11) were mated with Col2-Cre transgenic mice expressing the Cre recombinase under the control of the collagen ␣ 1 (II) chondrocyte-specific promoter (12) to obtain the Col2-Cre;Cyp27b1 ϩ/Ϫ genotype. These were mated to mice homozygous for a floxed Cyp27b1 allele (13) to yield mutant mice having one Cyp27b1 null allele, one Cyp27b1 floxed allele, and transgenic for Col2-Cre (genotype: Col2Cre;Cyp27b1 Ϫ/fl; referred to as Cyp27b1 Ϫ/CH⌬ herein). The Col2-Cyp27b1 transgenic strain was engineered by subcloning the 1.6 kb Cyp27b1 mouse cDNA fused in frame with a C-terminal FLAG epitope between the ␤-globin intron and the Simian virus 40 polyadenylation signal of the pSI expression vector (Promega Corp., Madison, WI). The resulting minigene was excised and inserted between the collagen ␣ 1 (II) promoter fragment/first exon sequences and the collagen ␣ 1 (II) intron 1 and enhancer sequences (14) . Plasmid construction details are available on request. The transgene was excised, purified, and used for pronuclear injection performed by the Québec Transgenesis Research Network (McGill University, Montréal, Qué-bec, Canada). Genotyping of all strains was performed using PCR under standard conditions (primer sequences available on request).
Calcemia
Two-day-old pups from the Col2-Cyp27b1 and Cyp27b1 Ϫ/CH⌬ strains were killed by decapitation. The blood was collected and centrifuged at 6000 ϫ g for 5 min after which the serum supernatant was collected. Total calcium from the serum was measured by the calcium reagent set (Pointe Scientific Inc., Canton, MI) following the manufacturer's recommendations.
Embryonic sample collection
Vaginal plugs were used as evidence of mating. Pregnant females were killed 14 or 15 d later to give 14.5-or 15.5-d-old embryos (E14.5 or E15.5), respectively. Uterine horns were placed in 10-ml petri dishes with 1ϫ PBS, and individual embryos were dissected out and placed in a 10-ml falcon tube containing 4% paraformaldehyde solution for overnight fixation (yolk sacs were kept for DNA extraction and subsequent genotyping). Embryonic hindlimbs were dissected out by using a Leica MZ6 dissecting microscope (Leica Microsystems, Richmond Hill, Ontario, Canada), to be embedded in paraffin. The paraffinized samples were sectioned at 5 m and stained with Harris hematoxylin and eosin (H&E).
Postnatal sample collection and processing
Tibias were collected at different ages (2, 14, and 42 d old) and fixed in 4% paraformaldehyde overnight. The following day, samples were processed to be either embedded in paraffin or methyl methacrylate.
Histomorphometry
The methyl methacrylate-embedded samples were sectioned at 5 m. Histomorphometric analysis was performed using the BioQuant Osteo II imaging software (BioQuant Image Analysis Corp., Nashville, TN).
Microcomputed tomography (CT) analysis
Scans were performed using a SkyScan 1072 instrument with a 12-bit cooled charge-coupled device camera and a 1024 ϫ 1024 pixels detector (Centre for Bone and Periodontal Research, McGill University).
Tartrate resistant acid phosphatase (TRAP) staining
Osteoclast number was determined using TRAP staining. Tibial sections from E15.5 and 2-d-old Cyp27b1 chondrocyte-specific knockout mice (Cyp27b1 Ϫ/CH⌬ and controls) were deparaffinized using four xylene washes (2 min each) followed by rehydration in 100, 95, and 70% ethanol solutions. The sections were then placed in acid-washed Coplin jars and incubated in media consisting of complete Burstone's media ϩ 50 mM sodium tartrate (pH 5.0) for 1 h at 37 C. The sections were then washed with distilled H 2 O for 10 min before being mounted with the water-soluble Vectashield (Vector Laboratories Inc., Burlington, Ontario, Canada) mounting media.
Proliferating cell nuclear antigen (PCNA) staining
Chondrocyte proliferation was assayed using the PCNA staining kit (Zymed Laboratories Inc., Markham, Ontario, Canada). E15.5 sections were deparaffinized and epitope retrieval was performed by incubating the sections in 10 mM sodium citrate buffer, pH 6.0 at 95 C for 10 min. The sections were then washed with distilled H 2 O and stained for PCNA following the manufacturer's instructions.
RNA isolation, reverse transcription, and real-time PCR
Total RNA was isolated from the rib cartilage and femoral epiphysis of Cyp27b1 Ϫ/CH⌬ knockouts (2 and 14 d old) and Col2-Cyp27b1 transgenics (2 d old). The thoracic cage was dissected out using fine tools cleaned with RNaseZap (Ambion, Austin, TX) to inactivate ribonucleases. The cartilaginous clear section between the mineralized sternum and the rest of the rib was carefully cut and placed in RNAlater (Ambion) solution to be stored at Ϫ20 C or placed in 1 ml of Trizol reagent (Invitrogen, Carlsbad, CA) for immediate RNA extraction using the manufacturer's recommendations. Samples were then reverse transcribed using either the high-capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA) or the high-capacity cDNA archive kit (Applied Biosystems). The relative expression of different chondrocyte differentiation markers and housekeeping genes was quantified using reverse transcription-quantitative PCR (RT-qPCR) on the reverse-transcribed mRNA from different samples with specific TaqMan (Applied Biosystems) probes. Following the manufacturer's instructions, 100 ng of double-stranded cDNA were added to a mix of TaqMan probes, universal PCR master mix (Applied Biosystems), and ribonuclease-free water. The RTqPCR was performed in an Applied Biosystems 7500 instrument (Applied Biosystems). Quantitative analysis was done using the comparative ⌬C t method and relative expression was normalized to Gapdh.
Immunohistochemistry
Platelet/endothelial cell adhesion molecule-1 (PECAM-1, also known as CD31) immunostaining was performed on the tibial primary growth plate of 2-d-old Cyp27b1 Ϫ/CH⌬ knockouts and control littermates. After deparaffinization, 3% hydrogen peroxide in 1ϫ PBS was added to the sections for 10 min to block endogenous peroxidase activity. The sections were then washed with 1ϫ PBS and blocked in a solution of 1.5% horse serum in 1ϫ PBS. After blocking, the sections were incubated with 10 g/ml of PECAM-1 (M-20) goat polyclonal primary antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA) in a humidified chamber for 1 h at room temperature. The sections were then washed with 1ϫ PBS and incubated with 5 g/ml of biotinylated antigoat secondary antibody (Vector Laboratories) in a humidified chamber for 30 min at room temperature. The sections were then washed with 1ϫ PBS, and signals were detected using the ABC staining system kit (Santa Cruz) following the manufacturer's recommendations. The number of PECAM-1-positive cells was counted within a constant 0.5 mm 2 area at the chondroosseous junction.
Fgf23 ELISA
Peripheral blood was collected from 10-d-old Cyp27b1
Ϫ/CH⌬ mice and controls. The blood was spun for 10 min at 6000 ϫ g after which the aqueous supernatant serum was harvested. Fifty microliters of serum were used to measure Fgf23 levels using the FGF23 ELISA kit (Kainos Laboratories, Tokyo, Japan) following the manufacturer's recommendations.
25OHD 3 supplementation
Eighteen nanograms (0.044 nmol) of 25OHD 3 (Hoechst Marion Roussel Inc., Cincinnati, OH) was sc injected daily into females starting 1 w after plug detection until delivery. Offspring were killed 2 d later and tibias were collected and processed into 70% ethanol solution for CT analysis. The rib cage was also collected and kept in RNAlater at Ϫ20 C for further RNA extraction and RT-qPCR.
Primary cultures of chondrocytes
One-day-old pups were killed and the rib cage was dissected out. The clear cartilaginous section of the ribs was taken out, discarding the leftover bony section along with the sternum. This cartilaginous piece was sequentially incubated in 1% trypsin (Life Technologies, Inc., Grand Island, NY) for 1 h followed by 0.02% collagenase D (Roche, Indianapolis, IN) for 3 h. After the enzymatic digestion of the extracellular matrix, the leftover cell tissue was collected by spinning at 1000 rpm for 5 min. The tissue was further cut into smaller pieces and plated in six-well plates with DMEM containing 10% fetal bovine serum (PAA, Etobicoke, Ontario, Canada), 50 g/ml ascorbic acid (Life Technologies), and 1ϫ antibiotic-antimycotic (Life Technologies) cocktail in an atmosphere of 5% CO 2 . The preparation was left untouched for 72 h after which the media was changed. Forty-eight hours later the preparation was trypsinized and centrifuged at 1000 rpm for 5 min. The pellet was resuspended in media, and the cells were plated in six-well plates after passing through a 40-m cell strainer (BD Falcon, Bedford, MA). The cells were left to grow until confluence by changing the media every 72 h after which they were passaged into 24-well plates at a seeding density of 20,000 cells/cm 2 . Then the cell cultures were again left to grow until confluence (ϳ1 wk), changing the media every 48 h. Once the cells reached confluency, they were incubated for 4, 8, or 24 h in a DMEM medium containing 10% charcoal-treated fetal bovine serum (HyClone, Logan, UT), 50 g/ml ascorbic acid, and 1ϫ antibiotic-antimycotic cocktail in the presence of 1 M 25OHD 3 . After incubation, the wells were incubated with 0.5 ml TRIzol reagent (Invitrogen), and the RNA was isolated following the manufacturer's recommendations.
Image acquisition
All sections were viewed on a Leica DM-R microscope, and the images were acquired using an Olympus DP70 camera and processed by its accompanying DPController software (GE Healthcare Bio-Sciences, Baie d'Urfe, Qué bec, Canada).
Statistics
Results are expressed as the mean Ϯ SEM. To assess the effect of genotype, data were compared by using the two-tailed student t test with the Prism 4 software (GraphPad Software Inc., La Jolla, CA). P Ͻ 0.05 was accepted as significant.
Results
Chondrocyte-specific Cyp27b1 loss of function
To examine the putative paracrine, autocrine, or intracrine role of locally synthesized 1,25(OH) 2 D 3 in growth plate chondrocytes, we generated mice having one Cyp27b1 null allele, one Cyp27b1 floxed allele, and transgenic for Cre recombinase under the control of the collagen ␣ 1 (II) promoter. The resulting animals (referred to as Cyp27b1 S1B and data not shown), and results from these animals are grouped and expressed as controls. Expression of Cyp27b1 was significantly reduced in samples from Cyp27b1 Ϫ/CH⌬ mutant mice (supplemental Fig. S1B ).
Chondrocyte-specific inactivation of Cyp27b1 did not affect the endocrine function of 1,25(OH) 2 D 3 as evidenced by the normal Ca 2ϩ serum levels measured in neonatal Cyp27b1 Ϫ/CH⌬ mice (Fig. 1 ).
Reduced Cyp27b1 levels affects embryonic chondrocyte development and neonatal endochondral ossification
To examine the effect of reduced Cyp27b1 expression on chondrocyte development, long bones were collected at intervals and examined using histomorphometry and CT. Measurement of the hypertrophic zone of H&E-stained E15.5 tibia showed a significant increase in the size of this zone in Cyp27b1 Ϫ/CH⌬ mice compared with controls ( Fig. 2A) . This was not due to increased chondrocyte proliferation because PCNA staining was identical between Cyp27b1 Ϫ/CH⌬ mice and controls (data not shown).
The increased size of the hypertrophic zone in the developing limb did not persist at the neonatal stage (Fig. 2B) .
On the other hand, the metaphyseal trabecular bone was increased at postnatal d 2. CT of the region encompassing the primary and secondary spongiosa of the bones showed an increase in bone volume, trabecular thickness, trabecular number, and a decrease in trabecular separation in Cyp27b1 Ϫ/CH⌬ mice compared with the controls (Fig. 2, C-F) . This phenotype was transient and all histomorphometric parameters showed no statistically significant differences between controls and Cyp27b1 Ϫ/CH⌬ mice at 14 or 42 d of age (data not shown).
Decreased osteoclast recruitment in embryonic and neonatal Cyp27b1
؊/CH⌬ mutant mice Masuyama et al. (10) observed an increased bone volume in neonatal chondrocyte-specific VDR knockouts, which they attributed to a decrease in RANKL mRNA expression and osteoclast recruitment at the chondroosseous junction at 2 d of age. This was also observed in the E15.5 cartilaginous anlagen of Cyp27b1 Ϫ/CH⌬ mice. We used TRAP staining to detect activated osteoclasts, which were reduced in number at the E15.5 femoral ossification center in Cyp27b1 Ϫ/CH⌬ mice when compared with controls (Fig. 3, A, B , and E). TRAP staining was also performed on 2-d-old long bones, in which we observed a reduced number of osteoclasts bordering the last row of hypertrophic chondrocytes at the chondroosseous junction in Cyp27b1 Ϫ/CH⌬ mice compared with controls ( Fig.   3 , C, D, and F). The expression of RANKL was also decreased in chondrocytes from 2-d-old Cyp27b1 Ϫ/CH⌬ animals (Fig. 3G) . 
Reduced/delayed vascularization in neonatal Cyp27b1
؊/CH⌬ mice
The rib cage contains a growth plate that can be dissected out to give a sample tissue enriched in chondrocytic cells. When gene expression monitoring using RT-qPCR was compared between rib cartilage and long bone epiphyses, identical gene expression patterns were observed (data not shown). We therefore used rib cartilage (a more homogeneous source of chondrocytes) to extract mRNA and monitor marker gene expression. Expression of vascular endothelial growth factor (VEGF) as well as its receptor (Kdr/VEGFR2) was reduced in Cyp27b1 Ϫ/CH⌬ mice (Fig. 4, A and B) . No change in the expression of Mmp13, a marker of chondrocyte differentiation involved in angiogenesis (15), was detected (Fig. 4C) . The differences in the mRNA expression of angiogenic markers prompted us to check vascularization of the neonatal epiphysis using PECAM-1 immunostaining of 2-d-old tibias. We observed reduced PECAM-1 staining in Cyp27b1 Ϫ/CH⌬ mice (Fig. 4, E and F) . When the number of PECAM-1-positive cells was quantified at the chondroosseous junction, we measured a significant decrease in Cyp27b1 Ϫ/CH⌬Ϫ mutant bones (Fig. 4D) . PECAM-1, also known as CD31, is a marker of the endothelial cells forming the blood vessels and its reduction suggests a decrease in vascularization at the chondroosseous junction.
Decreased Cyp27b1 expression perturbs neonatal chondrocyte differentiation
We also analyzed expression of chondrocytic markers by RT-qPCR on RNA extracted from rib chondrocytes at postnatal d 2. Indian Hedgehog (Ihh) and PTH/PTH-related peptide receptor (Pthr1) mRNA expression were increased in Cyp27b1 Ϫ/CH⌬ mice compared with controls (supplemental Fig. S2) . No difference in collagen ␣ 1 (II), collagen type X, and Hif1␣ expression levels could be measured (supplemental Fig. S2 ). The altered expression of chondrocyte differentiation markers did not persist beyond the early neonatal period and gene expression patterns were normalized at 14 or 42 d of age (data not shown). Due to limiting sample availability, we were not (Fig. 5) , however. This result agrees with the findings in chondrocyte-specific VDRablated mice (10).
Chondrocyte-specific Cyp27b1 overexpression
We contrasted the phenotype of the chondrocyte-specific ablation of Cyp27b1 with that of transgenic mice specifically overexpressing Cyp27b1 in chondrocytes. The Cyp27b1 cDNA was fused in frame with the FLAG epitope sequence at its 3Јend and subcloned between a chimeric intron and a polyadenylation stop sequence under the control of the collagen ␣ 1 (II) promoter elements (supplemental Fig. S3A ). The expression of the transgenic recombinant molecule was first confirmed in transient transfections of the chondrocytic ATDC5 cell line (17) (data not shown). The transgene was then injected in fertilized eggs, which resulted in a transgenic line expressing high levels of Cyp27b1 mRNA and protein in chondrocytes (strain 5Tg, supplemental Fig. S3, B and C) . Chondrocyte-specific overexpression of Cyp27b1 did not affect the circulating levels of Ca 2ϩ (data not shown).
Increased Cyp27b1 levels affect embryonic chondrocyte development
We collected long bones from Col2-Cyp27b1 transgenics at intervals and examined their phenotype by histomorphometry and CT. Measurement of the hypertrophic zone of H&E-stained E14.5 tibia showed a reduction in the size of this zone in transgenic mice compared with wild types (Fig. 6A) Pregnant females were injected daily with 25OHD 3 starting 1 wk after plug detection until delivery. Offspring (n ϭ 5 for wt and 10 for tg) were killed 2 d later, and tibias were collected for CT. Bone volume (B), trabecular thickness (C), and trabecular number (D) were decreased in transgenic mice compared with wild types. RNA isolated from 2-d-old rib cartilage was used to quantify RANKL expression by RT-qPCR (E). RANKL expression was also measured in chondrocytes from Col2-Cyp27b1 transgenic mice and wild-type littermates placed in primary culture and incubated with 25OHD 3 (F). *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001. BV/TV, Bone volume/tissue volume; Trab, trabecular; P2, postnatal d 2; tg, transgenic; wt, wild type.
Cyp27b1 enzyme. To test this possibility, 25OHD 3 , a metabolite that crosses the placenta (18) , was administered to gestating females. CT of the primary spongiosa of 2-d-old bones was then performed, which revealed a decrease in bone volume, trabecular thickness, and trabecular number in the treated transgenic mice compared with wild types (Fig. 6,  B-D) . This decrease in metaphyseal bone volume in the transgenics represents a mirror image phenotype to what was observed in Cyp27b1 Ϫ/CH⌬ mice. A change in the angiogenic markers was also expected to accompany this bone volume change; however, RT-qPCR performed on RNA extracted from the 2-d-old rib cartilage showed no difference in VEGF, or its receptor Kdr, mRNA expression (supplemental Fig.  S5 ). RANKL transcription was reciprocal to what we measured in Cyp27b1 Ϫ/CH⌬ mice and thus significantly increased (Fig. 6E) . The increase in RANKL expression was a cellautonomous effect. When chondrocytes from Col2-Cyp27b1 transgenic mice and wild-type littermates were placed in primary culture and incubated with 25(OH)D 3 , the expression of RANKL was significantly increased in transgenic cells after 4 and 8 h of incubation, before returning to levels measured in wild-type chondrocytes at 24 h (Fig. 6F) . These results confirm the expression of RANKL previously observed in chondrocytes (10, 19 ) and support a model in which the intracrine conversion of 25(OH)D 3 into 1,25(OH) 2 D 3 leads to activation of RANKL transcription.
Discussion
Vitamin D is classically thought to exert its effects on bone indirectly via control of calcium and phosphate homeostasis, despite expression of Cyp27b1 and the VDR in osteoblasts and chondrocytes (7) (8) (9) . However, aberrant growth plate development appears before the onset of hypocalcemia in VDR-deficient mice (20) , supporting a defined role for 1,25(OH) 2 D 3 -mediated signaling in endochondral bone formation. A role for 1,25(OH) 2 D 3 in growth plate function is further supported by the observation that rescuing mineral homeostasis of Cyp27b1-deficient mice with a high-calcium, high-lactose diet corrected all aspects of the phenotype except long bone growth (21) . Recently chondrocyte-specific ablation of the VDR was shown to cause delays in osteoclastogenesis, creating neonatal increases in bone volume at the chondroosseous junction (10) . (22) , the early bone anlagen is avascular and may rely on local synthesis of the active vitamin D metabolite to regulate target cell differentiation and function. Moreover, a recent concept in the field of sex steroids is intracrinology (23) . A significant proportion of androgens (ϳ50%) and estrogens (ϳ75% before menopause, and close to 100% after menopause) are produced in peripheral hormonetarget tissues that express steroid metabolic enzymes. These locally produced bioactive androgens and/or estrogens exert their action in the cells in which synthesis occurs without release in the extracellular space, including circulation. Thus, despite central steroidogenesis in the gonads, peripheral target tissues use on-the-spot intracellular hormone synthesis/action to regulate their function (23) . Support for such a mode of action for vitamin D was recently obtained through the study of macrophage-mediated innate immunity (5, 6). Liu et al. (5) identified both VDR and CYP27B1 as induced genes in Toll-like receptor-activated macrophages. The Toll-like receptor-mediated up-regulation of the expression of VDR and CYP27B1 provokes the intracrine 1,25(OH) 2 D 3 -dependent induction of cathelicidin and increased microbicidal activity of the macrophages (6) . These results demonstrate the physiological relevance of extrarenal Cyp27b1 expression in peripheral target tissues. Our results demonstrating increased RANKL expression after 25OHD 3 treatment of primary chondrocytes in culture support the intracrine conversion of the metabolite into the active, hormonal form. Chondrocyte-specific modulation of Cyp27b1 expression also did not affect calcemia, further supporting an intracrine, not an endocrine, effect of the engineered mutations.
The mating strategy that yielded the chondrocytespecific Cyp27b1 mutant mice (Cyp27b1 Ihh is a stimulator of chondrocyte proliferation and an inhibitor of chondrocyte hypertrophy (24) . Despite a stimulation in the expression of Ihh mRNA, we measured an increase in the size of the hypertrophic zone without changes in chondrocyte proliferation in Cyp27b1 Ϫ/CH⌬ mutant mice (Fig. 2 and data not shown) . Expression of hedgehog family members is highly regulated at both the posttranscriptional and posttranslational levels (25, 26) . We did not measure Ihh protein expression in the developing limbs of Cyp27b1 Ϫ/CH⌬ or Col2-Cyp27b1 mice, and it remains a possibility that the observed changes in mRNA levels were not accompanied by similar changes in protein levels, which would explain the apparent discrepancy. Based on the phenotype of Cyp27b1 Ϫ/CH⌬ mutant mice, we propose the following model: locally synthesized 1,25(OH) 2 D 3 regulates VEGF expression and signaling in the developing growth plate. In the absence of Cyp27b1, decreased VEGF expression would lead to a decrease in blood vessel formation. In turn, the vasculature delay reduces osteoclast invasion at the chondroosseous junction. Because osteoclasts resorb the calcified cartilaginous matrix that serves as the scaffold for woven bone formation, a reduction in osteoclast invasion would result in an increased scaffold size and thus a larger bone volume at the primary spongiosa. The model predicts that this phenotype is transient as blood vessels eventually invade the chondroosseous junction and normalize osteoclast recruitment and bone turnover. This model is supported in part by our observations and published results: we have measured decreased VEGF mRNA levels in chondrocytes from Cyp27b1 Ϫ/CH⌬ mutant mice (Fig. 4) . Similarly, VEGF mRNA levels were significantly reduced in mutant newborn growth plates from chondrocyte-specific VDR knockout mice (10) . We also observed a reduction in the protein levels of the endothelial cell/blood vessel marker PECAM-1 (Fig. 4) , which is consistent with decreased blood vessel formation.
Immunodetection of endothelial cells in developing tibia of chondrocyte-specific VDR mutant mice revealed a similar reduction in the number of invading blood vessels in the growth plate (10) . Both genetic models are consistent with and support the observation that short-term treatment of mice with 1,25(OH) 2 D 3 , under conditions in which calcemia is not perturbed, induces changes in VEGF expression and promotes vascularization of the chondroosseous junction (27) . It would prove interesting to attempt rescue of the decreased angiogenesis phenotype of Cyp27b1 Ϫ/CH⌬ mice by mating to chondrocyte-specific VEGF transgenic mice.
In the chondrocyte-specific VDR-ablated mice, Masuyama et al. (10) reported a reduction in the number of osteoclasts and a decrease in RANKL expression. We also observed an inhibition of RANKL transcription and reduced osteoclastogenesis at the chondroosseous junction of neonatal Cyp27b1 Ϫ/CH⌬ mutant mice (Fig. 3) . The expression of Fgf23 was reduced in the metaphysis of chondrocyte-specific VDR mutant mice (10) . In accordance with this report, we also measured a decrease in serum levels of Fgf23 in 10-d-old Cyp27b1 Ϫ/CH⌬ mice. The mechanisms that explain the regulation of Fgf23 expression by 1,25(OH) 2 D 3 at the growth plate remain to be completely determined but appear to involve a 1,25(OH) 2 D 3 -induced secreted factor from chondrocytes that affects Fgf23 production by neighboring osteoblasts (10) . Taken together, the results from genetic manipulation of the expression of Cyp27b1 (herein) or the VDR (10) in chondrocytes strongly support a direct role for locally synthesized 1,25(OH) 2 D 3 , acting through the VDR, in vascular invasion and osteoclastogenesis during endochondral bone development. 
